Corcept Therapeutics Incorporated (CORT)
Debt-to-assets ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | US$ in thousands | 840,553 | 784,257 | 714,555 | 655,935 | 621,517 | 594,022 | 524,625 | 617,848 | 583,430 | 533,255 | 496,364 | 468,123 | 423,756 | 585,399 | 568,480 | 552,398 | 571,731 | 534,125 | 497,823 | 445,494 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $840,553K
= 0.00
The debt-to-assets ratio of Corcept Therapeutics Incorporated has consistently remained at 0.00 over the reporting periods from March 31, 2020, to December 31, 2024. This indicates that the company has had no debt relative to its total assets during these periods. A debt-to-assets ratio of 0.00 signifies that the company is primarily financed by equity rather than debt, indicating a lower financial risk and potentially a stronger financial position. This stable ratio suggests that Corcept Therapeutics has effectively managed its debt levels and maintained a healthy balance between debt and assets in its capital structure.
Peer comparison
Dec 31, 2024